The Use of Dermal Papilla Cells in Studies of Normal and Abnormal Hair Follicle Biology

    October 1996 in “ Dermatologic Clinics
    Valerie A. Randall
    Image of study
    TLDR Dermal papilla cells are key for hair growth and could help us understand and treat hair loss.
    The document from 1996 highlights the significance of dermal papilla cells in the regulation of hair growth and their potential role in hair disorders like alopecia areata and androgenetic alopecia. It acknowledges the complexity of hair follicle biology and the challenges in fully understanding and controlling hair disorders. The discovery of hair growth-stimulating drugs such as minoxidil and finasteride suggests that dormant follicles can be reactivated. The dermal papilla, crucial for hair growth, is smaller in balding follicles, and androgens may influence hair follicles through these cells. Cultured dermal papilla cells, despite being difficult to grow and maintain, have been shown to retain hair growth-promoting properties and can initiate hair follicle development when transplanted into animals. The document concludes that further research into the factors produced by these cells could provide deeper insights into both normal and abnormal hair follicle function.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 1000+ results

      community Fats on your Head to Stop Hair Loss?

      in Research/Science  138 upvotes 9 months ago
      The conversation discusses the potential of long-chain unsaturated fatty acids, like oleic and linoleic acid, as an additional treatment for hair loss, which may inhibit the enzyme responsible for converting testosterone to DHT and promote hair growth. Users humorously suggest using oils topically and discuss other hair loss treatments, but the main focus is on the science behind fatty acids and their role in hair health.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  40 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community Fevipiprant 2019!

       17 upvotes 8 years ago
      The conversation discusses Fevipiprant, an asthma drug that may block CRTH2 and potentially stop male pattern baldness (MPB) without inhibiting DHT. It also mentions the use of finasteride and dutasteride for hair loss.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  44 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

    Related Research

    4 / 4 results